Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Desflurane for Hepatic Protection in Liver Transplantation
NCT02504138Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol injection (veterinary) in End-stage liver disease (ESLD) (2 arms), sponsored by Yonsei University. Primary endpoint: Hepatic function. Started Jun 2014; status: completed.
02
Drugs
propofol injection (veterinary)
03
Conditions
End-stage liver disease (ESLD)
Beyond the preview
Go deeper on NCT02504138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504138.